C-Reactive Protein and B-Type Natriuretic Peptide Yield Either a Non-Significant or a Modest Incremental Value to Traditional Risk Factors in Predicting Long-Term Overall Mortality in Older Adults

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Beleigoli, Alline M ^a   Boersma, Eric ^b   Diniz, Maria de Fátima H ^a   Vidigal, Pedro G ^a   Lima Costa, Maria Fernanda ^a,c   Ribeiro, Antonio L ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER;

AGED; ARTICLE; BLOOD ANALYSIS; BODY MASS; BRAZIL; CHAGAS DISEASE; CHOLESTEROL BLOOD LEVEL; DEATH CERTIFICATE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; HYPERTENSION; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHELOMETRY; PHYSICAL ACTIVITY; PREDICTION; RISK FACTOR; SMOKING; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; AGE; BLOOD; CAUSE OF DEATH; METABOLISM; MIDDLE AGED; OUTCOME ASSESSMENT; PROGNOSIS; STATISTICAL MODEL; SURVIVAL;

AGE FACTORS; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAUSE OF DEATH; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NATRIURETIC PEPTIDE, BRAIN; PATIENT OUTCOME ASSESSMENT; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84884541997     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075809     Document Type: Article

References (50)

1. WHO _CountryProfiles. Available: https://apps.who.int/infobase/CountryProfiles.aspx. Accessed: 2012 July 02.
2. Informações de, saúde. Available: http://www.datasus.gov.br. Accessed: 02 July 2012.
3. Cesari M, Onder G, Zamboni V, Capoluongo E, Russo A, et al. (2009) C-reactive protein and lipid parameters in older persons aged 80 years and older. J Nutr Health Aging 13: 587-593. doi:10.1007/s12603-009-0168-9. PubMed: 19621193.
4. Giovannini S, Onder G, Liperoti R, Russo A, Carter C, et al. (2011) Interleukin-6, C-reactive protein, and tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individuals. J Am Geriatr Soc 59: 1679-1685. doi:10.1111/j.1532-5415.2011.03570.x. PubMed: 21883115.
5. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, et al. (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106: 506-512. doi:10.1016/S0002-9343(99)00066-2. PubMed: 10335721.
6. Nakao K, Ogawa Y, Suga S, Imura H, (1992) Molecular biology and biochemistry of the natriuretic peptide system. I: Natriuretic peptides. J Hypertens 10: 907-912. PubMed: 1328371.
7. Nishikimi T, Maeda N, Matsuoka H, (2006) The role of natriuretic peptides in cardioprotection. Cardiovasc Res 69: 318-328. doi:10.1016/j.cardiores.2005.10.001. PubMed: 16289003.
8. Doust JA, Pietrzak E, Dobson A, Glasziou P, (2005) How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330: 625. doi:10.1136/bmj.330.7492.625. PubMed: 15774989.
9. Ribeiro AL, (2009) Natriuretic peptides in elderly people with acute myocardial infarction. BMJ 338: b787. doi:10.1136/bmj.b787. PubMed: 19420046.
10. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, et al. (2005) N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293: 1609-1616. doi:10.1001/jama.293.13.1609. PubMed: 15811980.
11. Ueda R, Yokouchi M, Suzuki T, Otomo E, Katagiri T, (2003) Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons. Am J Med 114: 266-270. doi:10.1016/S0002-9343(02)01525-5. PubMed: 12681452.
12. Shimizu Y, Nishinaga M, Takata J, Miyano I, Okumiya K, et al. (2009) B-type natriuretic peptide is predictive of hospitalization in community-dwelling elderly without heart diseases. Geriatr Gerontol Int 9: 148-154. doi:10.1111/j.1447-0594.2009.00514.x. PubMed: 19740358.
13. Wallén T, Landahl S, Hedner T, Nakao K, Saito Y, (1997) Brain natriuretic peptide predicts mortality in the elderly. Heart 77: 264-267. doi:10.1136/hrt.77.3.264. PubMed: 9093047.
14. Lima-Costa MF, Firmo JO, Uchoa E, (2011) Cohort profile: the Bambui (Brazil) Cohort Study of Ageing. Int J Epidemiol 40: 862-867. doi:10.1093/ije/dyq143. PubMed: 20805109.
15. Assuncao LG, Eloi-Santos SM, Peixoto SV, (2012) High sensitivity C-reactive protein distribution in the elderly: the Bambui Cohort Study, Brazil. Braz J Med Biol Res.
16. Myers GL, Christenson RH, Cushman M, Ballantyne CM, Cooper GR, et al. (2009) National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease. Clin Chem 55: 378-384. PubMed: 19106185.
17. Preis SR, Hwang SJ, Coady S, Pencina MJ, D'Agostino RB Sr., et al. (2009) Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 119: 1728-1735. doi:10.1161/CIRCULATIONAHA.108.829176. PubMed: 19307472.
18. de Ruijter W, Westendorp RG, Assendelft WJ, den Elzen WP, de Craen AJ, et al. (2009) Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. Bmj 338: a3083. doi:10.1136/bmj.a3083. PubMed: 19131384.
19. Sherman SE, D'Agostino RB, Cobb JL, Kannel WB, (1994) Does exercise reduce mortality rates in the elderly? Experience from the Framingham Heart Study. Am Heart J 128: 965-972. doi:10.1016/0002-8703(94)90596-7. PubMed: 7942491.
20. Beleigoli AM, Boersma E, Diniz, MdFH, Lima-Costa MF, Ribeiro AL (2012) Overweight and Class I Obesity Are Associated with Lower 10-Year Risk of Mortality in Brazilian Older Adults: The Bambui Cohort Study of Ageing. PLOS ONE 7: e52111. doi:10.1371/journal.pone.0052111. PubMed: 23251690.
21. Lima-Costa MF, Peixoto SV, Matos DL, Firmo JO, Uchôa E, (2011) Predictors of 10-year mortality in a population of community-dwelling Brazilian elderly: the Bambui Cohort Study of Aging. Cad Saude Publica 27 (Suppl 3):: S360-S369. doi:10.1590/S0102-311X2011001500006. PubMed: 21952857.
22. Lima-Costa MF, Barreto SM, Guerra HL, Uchoa E, Vidigal PG, (2001) Ageing with Trypanosoma cruzi infection in a community where transmission has been interrupted: the Bambuí Health and Aging Study (BHAS). Int J Epidemiol 30: 887-893. doi:10.1093/ije/30.4.887. PubMed: 11511622.
23. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, et al. (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 338: b2393. doi:10.1136/bmj.b2393. PubMed: 19564179.
24. D'Agostino R, Nam B, (2004) Evaluation of the performance of survival analysis models: discrimination and calibration measures Handbook of Statistics. Elsevier Science B.V.
25. Hanley JA, McNeil BJ, (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148: 839-843. PubMed: 6878708.
26. Harrell FE Jr., Lee KL, Mark DB, (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15: 361-387. doi:10.1002/(SICI)1097-0258(19960229)15:4. PubMed: 8668867.
27. Pencina MJ, D'Agostino RB Sr., D'Agostino RB Jr, Vasan RS, (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27: 157-172; discussion: 207-112. doi:10.1002/sim.2929. PubMed: 17569110.
28. Pencina MJ, D'Agostino RB Sr., Steyerberg EW, (2011) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30: 11-21. doi:10.1002/sim.4085. PubMed: 21204120.
29. Vasto S, Candore G, Balistreri CR, Caruso M, Colonna-Romano G, et al. (2007) Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev 128: 83-91. doi:10.1016/j.mad.2006.11.015. PubMed: 17118425.
30. Blackburn R, Giral P, Bruckert E, André JM, Gonbert S, et al. (2001) Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects. Arterioscler Thromb Vasc Biol 21: 1962-1968. doi:10.1161/hq1201.099433. PubMed: 11742871.
31. Cao JJ, Thach C, Manolio TA, Psaty BM, Kuller LH, et al. (2003) C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation 108: 166-170. doi:10.1161/01.CIR.0000079160.07364.6A. PubMed: 12821545.
32. Cushman M, Arnold AM, Psaty BM, Manolio TA, Kuller LH, et al. (2005) C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation 112: 25-31. doi:10.1161/CIRCULATIONAHA.104.504159. PubMed: 15983251.
33. Barbieri M, Ferrucci L, Ragno E, Corsi A, Bandinelli S, et al. (2003) Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am J Physiol Endocrinol Metab 284: E481-E487. PubMed: 12419777.
34. Penninx BW, Kritchevsky SB, Newman AB, Nicklas BJ, Simonsick EM, et al. (2004) Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc 52: 1105-1113. doi:10.1111/j.1532-5415.2004.52308.x. PubMed: 15209648.
35. Maugeri D, Russo MS, Franzé C, Motta V, Motta M, et al. (1998) Correlations between C-reactive protein, interleukin-6, tumor necrosis factor-alpha and body mass index during senile osteoporosis. Arch Gerontol Geriatr 27: 159-163. doi:10.1016/S0167-4943(98)00110-1. PubMed: 18653160.
36. Schett G, Kiechl S, Weger S, Pederiva A, Mayr A, et al. (2006) High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch Intern Med 166: 2495-2501. doi:10.1001/archinte.166.22.2495. PubMed: 17159016.
37. Cartier A, Côté M, Lemieux I, Pérusse L, Tremblay A, et al. (2009) Age-related differences in inflammatory markers in men: contribution of visceral adiposity. Metabolism 58: 1452-1458. doi:10.1016/j.metabol.2009.04.025. PubMed: 19595381.
38. Salanitro AH, Ritchie CS, Hovater M, Roth DL, Sawyer P, et al. (2012) Inflammatory biomarkers as predictors of hospitalization and death in community-dwelling older adults. Arch Gerontol Geriatr 54: e387-e391. doi:10.1016/j.archger.2012.01.006. PubMed: 22305611.
39. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, et al. (2005) N-Terminal Pro-Brain Natriuretic Peptide,C-Reactive Protein, and Urinary Albumin Levels as Predictors of Mortality and Cardiovascular Events in Older Adults. JAMA 293: 1609-1616. doi:10.1001/jama.293.13.1609. PubMed: 15811980.
40. Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, et al. (2012) Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation: A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy. Circulation 125: 1605-1616. doi:10.1161/CIRCULATIONAHA.111.038729. PubMed: 22374183.
41. Rost NS, Biffi A, Cloonan L, Chorba J, Kelly P, et al. (2012) Brain natriuretic peptide predicts functional outcome in ischemic stroke. Stroke 43: 441-445. doi:10.1161/STROKEAHA.111.629212. PubMed: 22116811.
42. Beleigoli AM, Lima-Costa MF, Diniz, MdFH, Ribeiro AL (2011) B-type natriuretic peptide and anthropometric measures in a Brazilian elderly population with a high prevalence of Trypanosoma cruzi infection. Peptides 32: 1787-1792. doi:10.1016/j.peptides.2011.08.013. PubMed: 21884743.
43. Tice JA, Browner W, Tracy RP, Cummings SR, (2003) The relation of C-reactive protein levels to total and cardiovascular mortality in older U.S. women. Am J Med 114: 199-205. doi:10.1016/S0002-9343(02)01497-3. PubMed: 12637134.
44. Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, et al. (2007) N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. Eur Heart J 28: 1374-1381. doi:10.1093/eurheartj/ehl448. PubMed: 17242007.
45. Rutten JH, Mattace-Raso FU, Steyerberg EW, Lindemans J, Hofman A, et al. (2010) Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: the Rotterdam study. Hypertension 55: 785-791. doi:10.1161/HYPERTENSIONAHA.109.143313. PubMed: 20083731.
46. Daniels LB, Laughlin GA, Clopton P, Maisel AS, Barrett-Connor E, (2008) Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. J Am Coll Cardiol 52: 450-459. doi:10.1016/j.jacc.2008.04.033. PubMed: 18672166.
47. Lima-Costa MF, Cesar CC, Peixoto SV, Ribeiro AL, (2010) Plasma {beta}-type natriuretic peptide as a predictor of mortality in community-dwelling older adults with Chagas disease: 10-Year follow-up of the Bambui Cohort Study of Aging. Am J Epidemiol 172: 190-196. doi:10.1093/aje/kwq106. PubMed: 20581155.
48. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, et al. (2006) Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 355: 2631-2639. doi:10.1056/NEJMoa055373. PubMed: 17182988.
49. Zethelius B, Berglund L, Sundström J, Ingelsson E, Basu S, et al. (2008) Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 358: 2107-2116. doi:10.1056/NEJMoa0707064. PubMed: 18480203.
50. Cook NR, (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115: 928-935. doi:10.1161/CIRCULATIONAHA.106.672402. PubMed: 17309939.